Home / Mass Tort / Active Dockets

Mass Tort · Active Dockets

Active mass tort dockets

The mass tort dockets Jim Glaser Law currently screens for Massachusetts residents. Each docket has a dedicated screening flow. The first telephone consultation is offered without charge; the line is answered 24/7. Cases that fit are filed by the firm or coordinated with national lead counsel; cases that do not fit are referred without fee where appropriate.

  1. 01 Actively Screening

    Silicosis from Engineered-Stone Exposure

    Massachusetts countertop fabricators, installers, and stone workers exposed to engineered-stone dust may have developed silicosis, an irreversible lung disease. A nationwide multidistrict litigation is in formation. Jim Glaser Law screens Massachusetts claims at no cost.

    Open the screening →
  2. 02 Actively Screening

    Mesothelioma from Asbestos Exposure

    Massachusetts residents diagnosed with mesothelioma after asbestos exposure (industrial work, shipyards, construction trades, military service, or secondary household exposure) may be entitled to recovery from manufacturers and asbestos trust funds. Jim Glaser Law screens claims at no cost.

    Open the screening →
  3. 03 Actively Screening

    Depo-Provera and Meningioma Risk

    Women who used Depo-Provera contraceptive injections long-term (one year or more) and have been diagnosed with meningioma (a brain tumor) may have a claim. A 2024 BMJ study linked long-term medroxyprogesterone use to increased meningioma risk. Jim Glaser Law screens Massachusetts claims at no cost.

    Open the screening →

What a Massachusetts mass tort docket actually is

A mass tort docket is a coordinated set of individual lawsuits brought by many plaintiffs against a common defendant or set of defendants, alleging a common cause of injury. The mechanism is typically multidistrict litigation under 28 U.S.C. sec. 1407, which consolidates the federal cases before a single transferee judge for the purpose of coordinated pretrial proceedings. Each plaintiff retains a separate case with separate damages and a separate attorney-client relationship; what is shared is the discovery, the expert development, and the bellwether trials that produce verdict data informing the eventual settlement framework. Massachusetts residents whose facts fit one of the active dockets participate as individual plaintiffs in the consolidated proceeding.

The other common mass tort mechanism is the class action under Federal Rule of Civil Procedure 23. Mass tort dockets and class actions are different procedurally. In a class action one representative plaintiff sues on behalf of a class with similar claims; the recovery is divided among the class. In a mass tort MDL each plaintiff has a separate case with separate damages. The active dockets listed here are MDL dockets; class certification is a separate procedural question handled in some consumer-protection and product cases but is not the mechanism for the latent-injury and product-defect dockets the firm currently screens.

Why dockets get added and how the firm screens for fit

A new docket forms when evidence accumulates that a specific product, drug, exposure, or platform has caused a pattern of injury that is foreseeable and provable. Plaintiff-side firms across the country coordinate to file individual cases that collectively prove the pattern; the cases are consolidated by the Judicial Panel on Multidistrict Litigation; lead counsel is appointed; discovery proceeds against the defendant. For an individual Massachusetts resident to participate in a docket, their facts must fit the docket's screening criteria. The criteria typically include exposure profile (when, where, what product or substance), injury type and severity (diagnostic confirmation, medical-record documentation, severity of impact), and timing (whether the injury occurred within the docket's covered window).

Jim Glaser Law's screening process for each active docket is designed to evaluate fit accurately and quickly. The screening captures the essential facts, requests the documentary record where available, and produces a fit determination within one business day. Cases that fit are accepted by the firm or coordinated with national lead counsel where the docket is coordinated through a lead-counsel structure. Cases that do not fit are not filed; the prospective client is told plainly that the matter does not fit the current docket criteria and is referred to other counsel without fee where appropriate.

Massachusetts plaintiffs in nationwide dockets

Massachusetts residents participating in a nationwide MDL file their individual cases in their home federal district (the District of Massachusetts) or in a district with jurisdiction over the defendant; the cases are then transferred to the MDL transferee court for coordinated proceedings. The Massachusetts statute of limitations applies to the substantive limitations analysis for Massachusetts plaintiffs (M.G.L. c. 260 sec. 2A for most tort claims), with the discovery rule extending the practical filing window where the connection between exposure and injury was not reasonably knowable at the time of exposure. For latent-injury dockets like asbestos exposure or engineered-stone silicosis, the discovery rule is critical because the injury can manifest decades after the exposure.

Recovery and timeline expectations

Mass tort matters typically run two to five years from filing to final settlement, although individual cases can resolve earlier or later. Recovery for a Massachusetts plaintiff in a mass tort docket depends on the documented injury severity, the exposure profile, the docket's tier structure if any, and the global settlement framework negotiated by lead counsel. Mass tort verdicts and settlements span a wide range; the range for any specific docket is best discussed on a free intake call once the screening has confirmed fit. The firm does not promise outcomes on any specific matter and the fee agreement at intake makes the contingency arrangement explicit: no attorney fee unless and until a recovery, with case-related costs and expenses addressed in writing.

Why the firm screens dockets at no cost

Mass tort dockets at intake are evaluated by the firm at no cost because the contingency-fee posture for the eventual representation only pays the firm if the matter resolves with a recovery to the client. The economic incentive is aligned across the screening stage and the representation stage: neither party wants to invest in a matter that does not have the documentary record or the fact pattern to qualify for the docket. Screening at no cost is the right model. It is also the right model from the public-interest perspective: the combination of latent-injury patterns and rapidly evolving docket criteria means most Massachusetts residents who might qualify for a docket have no idea, and screening at no cost makes the determination accessible regardless of whether the client can pay an evaluation fee.

What clients should expect during their participation in a docket

Participation in a Massachusetts mass tort docket has a few distinct phases. After the screening confirms fit, the firm opens a file and the client signs a written fee agreement. The complaint is then prepared (typically from a template developed for the docket) and filed in the appropriate federal court for transfer to the MDL transferee court. Once the case is in the MDL, the centralized discovery process begins; the client may be asked to provide medical records, employment records, exposure history, and other documentation that the docket requires. Some clients are selected as bellwether plaintiffs, whose cases proceed to trial first to produce verdict data; most clients are not selected and their cases wait for the eventual global settlement framework.

Communication during the pendency of the docket comes in two forms. The firm provides individual case updates as material developments occur in the client's specific case. The firm also provides docket-wide updates as bellwether trials are scheduled, settlement frameworks are negotiated, and the tier structure for the eventual global settlement is announced. Material decisions on the client's individual case (acceptance of a settlement offer in the global framework, election to opt out of a settlement framework to pursue an individual trial, election to dismiss) are made jointly by the firm and the client.

How active dockets get added and retired

A mass tort docket is added to the firm's screening roster when three conditions are met. First, the evidence-of-causation record reaches a threshold: peer-reviewed studies, regulatory findings, or internal corporate documents demonstrating that the product, drug, or exposure caused the alleged injury type at a foreseeable rate. Second, the procedural posture has consolidated: a federal MDL has been formed and a transferee court appointed, or a state mass-action procedure is available. Third, the available recovery pool is sufficient to make individual representation economically viable on contingency. Without all three, the docket is not actionable yet and the firm waits.

A docket is retired from the active roster when one of these occurs. Global settlement framework is fully distributed and new cases are no longer being accepted. Statute of limitations for new claims has elapsed across most relevant jurisdictions. Defendant has entered bankruptcy and recovery for new plaintiffs is no longer available. The underlying scientific evidence has been substantially undermined and the docket is unlikely to produce recoveries that justify the engagement. The firm reviews active dockets quarterly against these criteria; the roster on this page reflects the current actionable set.

What clients should know about MDL settlement frameworks

Mass tort dockets typically resolve through a tiered global settlement framework rather than individual case-by-case verdicts. The framework is negotiated between national lead counsel and the defendant after enough bellwether trials have produced verdict data to establish a settlement range. Each plaintiff is then assigned to a tier based on documented injury severity, exposure profile, treatment history, and other case-specific factors that the docket administrator evaluates. The tier determines the base settlement amount; adjustments can move a specific case up or down within a tier based on documentation strength. Each plaintiff retains the right to opt out of the settlement framework and pursue individual trial, but most accept the framework because individual mass tort trials are expensive and uncertain. The firm walks each client through the framework when it is announced and recommends an acceptance or opt-out path based on the specific case posture.

Frequently asked questions about mass tort dockets

  • What dockets does Jim Glaser Law currently screen?

    Three active dockets: silicosis from engineered-stone exposure, mesothelioma from asbestos exposure, and Depo-Provera meningioma claims. Each has a dedicated screening flow linked from this page. The roster of active dockets changes over time as new evidence supports new dockets and as existing dockets reach global resolution.

  • Is screening free?

    Yes. Mass tort screening is offered at no cost and in confidence by Jim Glaser Law. No fee is owed unless and until the matter resolves with a recovery. The screening produces a fit determination within one business day and either an engagement letter or a clear statement that the matter does not fit the current docket criteria.

  • How do I start a screening?

    Telephone (617) JIM-WINS or visit the dedicated docket page for the matter that fits your situation. The intake line is answered 24 hours a day, 7 days a week. The first telephone consultation with the firm is offered without charge.

  • Are these cases limited to Massachusetts residents?

    No. Mass tort dockets typically have nationwide reach because the underlying product, exposure, or conduct affected residents across many states. Massachusetts residents are screened directly by Jim Glaser Law. Out-of-state inquiries are referred to partner counsel admitted in the relevant jurisdiction without fee.

  • How is a mass tort case different from a regular lawsuit?

    Mass tort cases are coordinated through multidistrict litigation procedure under 28 U.S.C. sec. 1407. Each plaintiff retains a separate case while sharing discovery costs and bellwether trial work with other plaintiffs in the docket. A regular lawsuit is a standalone proceeding. The mass tort posture lets individual plaintiffs access the depth of investigation that the defendant brings to its side without bearing the full cost.

Past results do not guarantee future outcomes. Mass tort representation is typically on contingency, meaning no attorney's fee unless and until the matter resolves with a recovery to the client; case-related costs and expenses are addressed in the written fee agreement. Attorney advertising under Mass. R. Prof. C. 7.1 to 7.5. Responsible attorney: Jim Glaser, Massachusetts.